Outset Medical, Inc.

NASDAQ:OM

Medical - Devices

Healthcare
$3.04 +18.16%

+$0.73 today

Market cap
$57.31M
Beta
1.94
P/E (TTM)
-1.2
EPS (TTM)
-$4.07
52W Low $3.00High $21.36

Volume 0.05M

Average 0.16M

OM Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

Outset Medical, Inc.NASDAQ: OM

Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026

Cost of revenue declines year over year

Q1 FY2026 cost of revenue of $15.77M fell 15.6% year over year, behind the -5.5% change in trailing-twelve-month cost of revenue. Sequentially, it fell 5.3% from the prior quarter. Over 3 fiscal years it compounded at -9.3% a year.

Context

  • Cost of revenue amounted to 60.9% of revenue in FY2025, down 5.2 pp from a year earlier.
  • Cost of revenue increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -15.6% toward the trailing-twelve-month pace of -5.5%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$15.77M-5.3% QoQ
Last fiscal yearDec 2025
$72.72M-3.2% YoY
LTMMar 2026
$69.8M-5.5% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-15.6%——
1 year-3.2%——
3-year CAGR-9.3%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
72.72M USD
Year-over-year change
-3.2%
4-year CAGR
-6.5%

Cost of Revenue vs competitors

How OM compares with its peers on the latest reported figures

  • OM's LTM Mar 2026 cost of revenue of $69.8M is the 4th highest of the 10 companies compared; the peer median is $13.21M.
  • Its year-over-year change of -5.5% is the 8th highest of 9, against a peer median of +22.3%.
  • Cost of revenue amounts to 59.4% of revenue for OM, versus a peer median of 44.9%.
OM Competitors Peer median
Cost of Revenue for OM and competitors
Company Period LTM YoY 3-year CAGR% of revenue
INGNInogen, Inc.LTM Mar 2026$180.21M -1.6%-6.5%51.3%
VMDViemed Healthcare, Inc.LTM Mar 2026$122.3M +27.2%+28.5%42.7%
QTRXQuanterix CorporationLTM Mar 2026$80.87M +47.8%+7.1%55.8%
OMOutset Medical, Inc.LTM Mar 2026$69.8M -5.5%-9.3%59.4%
NNOXNano-X Imaging Ltd.LTM Dec 2025$25.81M +17.4%+18.6%198.2%
SIShoulder Innovations, Inc.LTM Mar 2026$13.21M +53.2%—24.5%
SNWVSANUWAVE Health, Inc.LTM Mar 2026$10.78M +27.5%+32.5%24.3%
CATXPerspective Therapeutics, Inc.LTM Mar 2026$2.63M ——426.2%
HSDTSolana CompanyLTM Mar 2026$559K -3.6%+2.6%5.8%
TNYATenaya Therapeutics, Inc.LTM Mar 2026-$101K -104.8%-1.1%44.9%
Peer median (excluding OM) $13.21M+22.3%+7.1%44.9%

Competitors are the stored peer set for OM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue102.6M115.38M130.38M113.69M119.48M
Cost of Revenue94.99M97.54M101.38M75.13M72.72M
Gross Profit7.61M17.83M29M38.56M46.75M
Gross Margin7.4%15.5%22.2%33.9%39.1%
Research & Development36.74M48.86M57.31M38.4M21.24M
Selling, General & Admin101.39M130M141.46M113.54M92.23M
Operating Expenses138.13M178.85M198.77M151.94M113.46M
Depreciation & Amortization5.16M6.28M5.81M5.73M4.34M
EBITDA(124.86M)(152.81M)(153.79M)(97.89M)(62.37M)
EBITDA Margin-121.7%-132.4%-118.0%-86.1%-52.2%
Operating Income(130.52M)(161.02M)(169.77M)(113.38M)(66.71M)
Operating Margin-127.2%-139.6%-130.2%-99.7%-55.8%
Interest Income498K3.29M10.17M9.76M7.41M
Interest Expense1.72M3.57M12.68M23.87M13.95M
Other Income / Expenses(1.22M)(1.64M)(2.5M)(14.11M)(14.22M)
Income Before Tax(131.74M)(162.66M)(172.27M)(127.49M)(80.94M)
Pre-Tax Margin-128.4%-141.0%-132.1%-112.1%-67.7%
Income Tax Expense199K295K523K491K718K
Net Income(131.94M)(162.96M)(172.8M)(127.98M)(81.65M)
Net Margin-128.6%-141.2%-132.5%-112.6%-68.3%
EPS (Basic)(43.41)(50.75)(52.27)(36.95)(5.37)
EPS (Diluted)(43.41)(50.75)(52.27)(36.95)(5.37)
Weighted Avg Shares3.04M3.21M3.31M3.46M15.21M
Weighted Avg Shares (Diluted)3.04M3.21M3.31M3.46M15.21M

Outset Medical, Inc.

NASDAQ:OM

Intrinsic Alpha fair value

Locked

Current Price

$3.04

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.